-to-income ratio excluding loss from sale of foreclosed assets and loss from revaluations stood at 47.8% for 1Q18 comparing to 47.2% yoy. Bad debts and doubtful accounts and loss on debt restructuring

15,822 million baht at the end of fiscal year 2017. Consequently, book value as of November 30, 2018 was 69 baht per share, increased from 62.9 baht per share as of February 28, 2018. Debt to Equity ratio

financing cost at the end of 2019 stood at 2.91% Net debt to equity ratio stood at 0.37x Capital Structure As of December 31, 2019, the Company reported total interest-bearing debt of THB 33,210 mn, an

debenture. As a result, the financing cost was reduced. As 30 September 2019, the Company debt to equity ratio (D/E) equal to 0.94 times. Page 3 Net Profit The Company net profit for the 9-month period ended

32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine

deliver yet xxx xxx 4. total binding securities xxx xxx (3) Investments in debt instrument under the remain period of contract It shall disclose current period detail and comparative period, as follow 20

each category of investments in debt and net equity securities namely cost price, price writing-off cost, current (Translation) -27- purchasing price, discounted cash-flow analysis price, accounting

net equity securities It shall disclose the rule of fair value assessment of each category of investments in debt and net equity securities namely cost price, price writing-off cost, current

Financial and Ratio As at 30 September 2019 2018 Liquidity Ratio Current Ratio (Time) 1.4 1.5 Quick Ratio (Time) 4.6 4.7 Collection Period (Day) 22.0 22.5 Stock Turnover Period (Day) 8.3 8.3 Payment Period

-Mar- 2020 Profitability Ratios Liquidity Ratios Gross profit 1 (%) 33.7% 24.0% Current ratio (times) 1.3 0.8 Operating EBITDA (%) 16.2% -11.2% Quick ratio6 (times) 1.2 0.8 Net profit (incl. minority